EMA towards the withdrawal of J&J and Astra-Zeneca (Vaxevria)? There will be problems in vaccination campaigns
According to what reported by La Stampa and Affaritaliani , the Johnson & Johnson Janssen and Astra Zeneca Vaxevria vaccines are being withdrawn by order of the European drug control body EMA. If the studies in progress were to demonstrate an incidence of rare cases of cerebral thrombosis higher than normal even in the elderly population, then one could only proceed with the withdrawal of the vaccines in question, as the indications relating to the age groups so far used would not be more valid. The same effect could be had if there was a strong lowering effect on the number of platelets in the blood.
On J&J the European drug agency, Ema, will give an update next week, but the expert of the Italian Aifa, Patrizia Popoli, anticipates that "it is likely that it can be reserved for the over 60s". But clearly if this category were also at risk, we could not go on.
However, there will be major problems for the vaccination campaign: the Ministry of Health had ordered the following doses of the vaccine in December
- Johnson & Johnson 53.84 million
- Sanofi 40.38 million
- Pfizer / BNT 26.92 million
- CureVac 30.285 million
- Modern 10.768 million
Sanofi is there to come while of the two mRNAs, Pfizer and Moderna, we have ordered very few. What can be done? Speed up the production of these vaccines to the max for sure. It is also possible to accelerate the development of the serum studied by Professor Zuccotti , dean of the Faculty of Medicine in Milan, not a mythomaniac, and which seems to work. Investigations can be accelerated on Spunik V which, according to the Russians, does not cause clot problems and has started to be produced in Serbia. In short, if you do not want to blow up the vaccination campaign you have to move.
Thanks to our Telegram channel you can stay updated on the publication of new articles of Economic Scenarios.
The EMA article towards the withdrawal of J&J and Astra-Zeneca (Vaxevria)? There will be problems in vaccination campaigns comes from ScenariEconomici.it .
This is a machine translation of a post published on Scenari Economici at the URL https://scenarieconomici.it/ema-verso-il-ritiro-di-jj-e-astra-zeneca-vaxevria-se-ci-saranno-problemi-nelle-campagne-vaccinali/ on Thu, 15 Apr 2021 09:48:56 +0000.